Lv Q - Search Results

1

Identification of candidate biomarker EMP3 and its prognostic potential in clear cell renal cell carcinoma.

Lv Q, Xiao W, Xiong Z, Shi J, Miao D, Meng X, Yuan H, Yang H, Zhang X. Lv Q, et al. Front Biosci (Landmark Ed). 2021 Nov 30;26(11):1176-1190. doi: 10.52586/5018. Front Biosci (Landmark Ed). 2021. PMID: 34856762 Free article.

2

The Downregulation of Prognosis- and Immune Infiltration-Related Gene CYFIP2 Serves as a Novel Target in ccRCC.

Tong J, Meng X, Lv Q, Yuan H, Li W, Xiao W, Zhang X. Tong J, et al. Among authors: lv q. Int J Gen Med. 2021 Oct 11;14:6587-6599. doi: 10.2147/IJGM.S335713. eCollection 2021. Int J Gen Med. 2021. PMID: 34703279 Free PMC article.

3

HIF2α promotes tumour growth in clear cell renal cell carcinoma by increasing the expression of NUDT1 to reduce oxidative stress.

Shi J, Xiong Z, Wang K, Yuan C, Huang Y, Xiao W, Meng X, Chen Z, Lv Q, Miao D, Liang H, Xu T, Xie K, Yang H, Zhang X. Shi J, et al. Among authors: lv q. Clin Transl Med. 2021 Nov;11(11):e592. doi: 10.1002/ctm2.592. Clin Transl Med. 2021. PMID: 34841698 Free PMC article.

4

As a prognostic biomarker of clear cell renal cell carcinoma RUFY4 predicts immunotherapy responsiveness in a PDL1-related manner.

Miao D, Shi J, Xiong Z, Xiao W, Meng X, Lv Q, Xie K, Yang H, Zhang X. Miao D, et al. Among authors: lv q. Cancer Cell Int. 2022 Feb 8;22(1):66. doi: 10.1186/s12935-022-02480-7. Cancer Cell Int. 2022. PMID: 35135552 Free PMC article.

5

N6-methyladenosine-modified DBT alleviates lipid accumulation and inhibits tumor progression in clear cell renal cell carcinoma through the ANXA2/YAP axis-regulated Hippo pathway.

Miao D, Wang Q, Shi J, Lv Q, Tan D, Zhao C, Xiong Z, Zhang X. Miao D, et al. Among authors: lv q. Cancer Commun (Lond). 2023 Apr;43(4):480-502. doi: 10.1002/cac2.12413. Epub 2023 Mar 1. Cancer Commun (Lond). 2023. PMID: 36860124 Free PMC article.

6

Comprehensive analyses of A 12-metabolism-associated gene signature and its connection with tumor metastases in clear cell renal cell carcinoma.

Tan D, Miao D, Zhao C, Shi J, Lv Q, Xiong Z, Yang H, Zhang X. Tan D, et al. Among authors: lv q. BMC Cancer. 2023 Mar 23;23(1):264. doi: 10.1186/s12885-023-10740-6. BMC Cancer. 2023. PMID: 36949462 Free PMC article.

7

The m6A modification-mediated OGDHL exerts a tumor suppressor role in ccRCC by downregulating FASN to inhibit lipid synthesis and ERK signaling.

Shi J, Miao D, Lv Q, Wang K, Wang Q, Liang H, Yang H, Xiong Z, Zhang X. Shi J, et al. Among authors: lv q. Cell Death Dis. 2023 Aug 25;14(8):560. doi: 10.1038/s41419-023-06090-7. Cell Death Dis. 2023. PMID: 37626050 Free PMC article.

8

ENO2 as a Biomarker Regulating Energy Metabolism to Promote Tumor Progression in Clear Cell Renal Cell Carcinoma.

Shi J, Miao D, Lv Q, Tan D, Xiong Z, Zhang X. Shi J, et al. Among authors: lv q. Biomedicines. 2023 Sep 9;11(9):2499. doi: 10.3390/biomedicines11092499. Biomedicines. 2023. PMID: 37760940 Free PMC article.

9

miR-1182-mediated ALDH3A2 inhibition affects lipid metabolism and progression in ccRCC by activating the PI3K-AKT pathway.

Lv Q, Shi J, Miao D, Tan D, Zhao C, Xiong Z, Zhang X. Lv Q, et al. Transl Oncol. 2024 Feb;40:101835. doi: 10.1016/j.tranon.2023.101835. Epub 2023 Nov 30. Transl Oncol. 2024. PMID: 38039946 Free PMC article.

10

HIF2α Promotes Cancer Metastasis through TCF7L2-Dependent Fatty Acid Synthesis in ccRCC.

Shi J, Lv Q, Miao D, Xiong Z, Wei Z, Wu S, Tan D, Wang K, Zhang X. Shi J, et al. Among authors: lv q. Research (Wash D C). 2024 Feb 22;7:0322. doi: 10.34133/research.0322. eCollection 2024. Research (Wash D C). 2024. PMID: 38390305 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,831 results

Search Page

Filters